TY - JOUR
T1 - Integrating a complementary medicine consultation for women undergoing chemotherapy
AU - Ben-Arye, Eran
AU - Schiff, Elad
AU - Raz, Orit G.
AU - Samuels, Noah
AU - Lavie, Ofer
PY - 2014/1
Y1 - 2014/1
N2 - Objective To explore oncology healthcare providers' (HCPs') patterns of referral of women undergoing chemotherapy to a complementary medicine (CM) consultation integrated within a conventional oncology service. Methods Oncology HCPs used a structured referral system for referral to an integrative physician (IP) for CM consultation. Referral goals were in accordance with a specified list of quality-of-life (QOL) outcomes. Results In total, the study HCPs referred 282 female patients, of whom 238 (84.4%) underwent CM consultation by the study IP: 59 (24.8%) with gynecologic cancer and 179 (75.2%) with non-gynecologic cancer. Use of CM for cancer-related outcomes was significantly higher among referred patients with gynecologic cancer than those with non-gynecologic cancer (69.5% vs 46.9%; P = 0.003). Oncologists initiated most of the referrals in the gynecologic oncology group, whereas oncologic nurses referred most patients in the non-gynecologic oncology group. Among patients with gynecologic cancer, the correlation between HCP indication and patient expectation was high for gastrointestinal concerns (κ 0.41). Conclusion The integration of a structured and informed process of referral to CM consultation may enhance patient-centered care and QOL during chemotherapy.
AB - Objective To explore oncology healthcare providers' (HCPs') patterns of referral of women undergoing chemotherapy to a complementary medicine (CM) consultation integrated within a conventional oncology service. Methods Oncology HCPs used a structured referral system for referral to an integrative physician (IP) for CM consultation. Referral goals were in accordance with a specified list of quality-of-life (QOL) outcomes. Results In total, the study HCPs referred 282 female patients, of whom 238 (84.4%) underwent CM consultation by the study IP: 59 (24.8%) with gynecologic cancer and 179 (75.2%) with non-gynecologic cancer. Use of CM for cancer-related outcomes was significantly higher among referred patients with gynecologic cancer than those with non-gynecologic cancer (69.5% vs 46.9%; P = 0.003). Oncologists initiated most of the referrals in the gynecologic oncology group, whereas oncologic nurses referred most patients in the non-gynecologic oncology group. Among patients with gynecologic cancer, the correlation between HCP indication and patient expectation was high for gastrointestinal concerns (κ 0.41). Conclusion The integration of a structured and informed process of referral to CM consultation may enhance patient-centered care and QOL during chemotherapy.
KW - Complementary medicine
KW - Doctor-patient communication
KW - Gynecologic oncology
KW - Integrative medicine
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=84891161665&partnerID=8YFLogxK
U2 - 10.1016/j.ijgo.2013.07.019
DO - 10.1016/j.ijgo.2013.07.019
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 24140221
AN - SCOPUS:84891161665
SN - 0020-7292
VL - 124
SP - 51
EP - 54
JO - International Journal of Gynecology and Obstetrics
JF - International Journal of Gynecology and Obstetrics
IS - 1
ER -